SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabien Tech. Regulatory News (SNT)

Share Price Information for Sabien Tech. (SNT)

Share Price is delayed by 15 minutes
Get Live Data
3.75    0.00 (0.00%)
Bid:
3.50
Ask:
4.00
Spread: 0.50 (14.286%)
Market Cap: £1.19m
SNT Live PriceLast checked at - London Stock Exchange

Intraday Sabien Tech. Share Chart

AGM Statement

29 Nov 2023 07:30

RNS Number : 0485V
Sabien Technology Group PLC
29 November 2023

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION 11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310.

The directors take responsibility for this announcement.

29 November 2023

Sabien Technology Group plc

("Sabien" or the "Company")

Sabien Technology Group plc (AIM:SNT), the company focused on a green aggregation strategy, will hold its Annual General Meeting today at Peterhouse Capital Limited, 80 Cheapside, London, EC2V 6DZ, commencing at 11.00am.

At this meeting, Richard Parris, Executive Chairman, will make the following statement.

"The Company's financial year 2023 saw considerable progress in both M2G and b.grn, which progress has continued since the year end. Sabien has built, and is building, a portfolio of businesses whose development is expected to produce a range of outcomes across a range of timescales.

M2G represents success in the near term while b.grn is expected to contribute materially within the medium to long term. These are not mutually exclusive. Our work within the HVAC market brings important intelligence for the development of our plastic-to-fuel operation. Our development of b.grn has informed our work within the markets facing M2G, not least geographically.

I am pleased to report that M2G has delivered against challenging expectations. Carbon savings using M2G have almost tripled while Cloud Connect installations are now nearly twice that of a year ago. Since year end, new orders and revenue growth have extended the strongly positive trend during the last financial year. The business has maintained a robust financial position allowing it to further evolve its product offering and geographic footprint.

b.grn has continued to build its relationship successfully with City Oil Field ("COF") and its understanding of the available markets. The Board expects to deliver on key milestones in the year to June 2024.

The Board looks forward to another year of operational progress and financial delivery."

For Further Information:

Sabien Technology Group plc

Richard Parris, Executive Chairman +44 20 7993 3700

Scott Fulton, Investor Relations scott.fulton@sabien.com

Allenby Capital Limited (Nominated Adviser)

John Depasquale / Nick Harriss /Vivek Bhardwaj +44 203 328 5656

Peterhouse Capital Limited (Broker)

Duncan Vasey / Lucy Williams +44 207 469 0930

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
AGMBLBRTMTTTMMJ
Date   Source Headline
3rd Aug 201511:40 amRNSHolding(s) in Company
28th Jul 20152:39 pmRNSDirector/PDMR Shareholding
28th Jul 20157:00 amRNSAdmission of Placing and Subscription Shares
20th Jul 20157:00 amRNSIssue of Equity
15th Jun 20157:00 amRNSTrading Statement
7th Apr 20156:03 pmRNSDirector/PDMR Shareholding
27th Mar 20156:04 pmRNSDirector/PDMR Shareholding
16th Mar 20155:28 pmRNSDirector Shareholding
10th Feb 20157:00 amRNSHalf Yearly Report
7th Jan 20159:38 amRNSHolding(s) in Company
7th Jan 20159:36 amRNSHolding(s) in Company
20th Nov 20149:27 amRNSAGM Statement
27th Oct 20144:43 pmRNSDispatch of Annual Report and notice of AGM
9th Oct 20149:35 amRNSDividend Declaration
7th Oct 20147:00 amRNSPreliminary results for the year to 30 June 2014
3rd Oct 20143:54 pmRNSHolding(s) in Company
30th Sep 20149:39 amRNSHolding(s) in Company
12th Aug 20144:11 pmRNSHolding(s) in Company
6th Aug 20144:30 pmRNSHolding(s) in Company
1st Aug 201411:03 amRNSExercise of Warrants
8th Jul 20147:00 amRNSPost close trading update
29th May 20147:00 amRNSTrading Statement
28th Mar 20142:58 pmRNSDirector/PDMR Shareholding
3rd Mar 20147:00 amRNSOrders received
14th Feb 20145:01 pmRNSHolding(s) in Company
11th Feb 20147:00 amRNSInterim results
16th Jan 201410:58 amRNSDirector Shareholding
20th Nov 20134:32 pmRNSResult of AGM
28th Oct 20134:55 pmRNSNotice of AGM
23rd Oct 201312:19 pmRNSPropose Dividend Declaration
22nd Oct 20134:48 pmRNSHolding(s) in Company
10th Oct 201310:18 amRNSHoldings in Company
7th Oct 20137:00 amRNSPublic Sector Tender Award
1st Oct 20137:00 amRNSPreliminary Final Results
9th Jul 201312:45 pmRNSFurther Orders Received
8th Jul 20137:00 amRNSTrading Statement
7th Jun 20137:00 amRNSFurther orders received
28th May 20137:00 amRNSNew orders received
10th Apr 20137:00 amRNSContract with Norland
3rd Apr 201311:04 amRNSDirector Shareholding
26th Mar 20137:00 amRNSFireye Distributorship Agreement
12th Feb 20139:29 amRNSHolding(s) in Company
12th Feb 20137:00 amRNSHalf Yearly Report
6th Feb 20133:44 pmRNSHolding(s) in Company
6th Feb 20133:11 pmRNSChange of ACD for OEIC holding
31st Jan 201310:11 amRNSNotice of Results
22nd Nov 20127:00 amRNSAGM Statement
30th Oct 201210:44 amRNSGrant of share options
29th Oct 201210:19 amRNSDispatch of Annual Financial Report
17th Oct 20127:00 amRNSAppointment of Mrs Miriam Maes as a Director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.